Somatostatin receptor scintigraphy is a key diagnostic tool in the initial staging and therapeutic evaluation of neuroendocrine tumors. Its specificity can be compromised by the presence of false positives. We illustrate here the case of a vertebral hemangioma detected on Tc-Tektrotyd scintigraphy as an incidental finding in a 34-year-old man referred for the staging of a well-differentiated neuroendocrine tumor of the ampulla of Vater (Fig. 1).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654281 | PMC |
| http://dx.doi.org/10.1007/s13139-023-00803-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Optic nerve sheath meningioma detected by somatostatin receptor scintigraphy with [99mTc]Tc-Tektrotyd.
Nucl Med Rev Cent East Eur
November 2024
Department of Nuclear Medicine, Mohammed V Military Hospital, Mohammed V University of Rabat, Morocco.
Article Synopsis
- - Optic nerve sheath meningiomas are rare tumors that can lead to vision loss, making accurate diagnosis challenging, especially since confirming their presence often requires risky procedures.
- - Current diagnostic methods primarily include CT and MRI, but these imaging techniques may not always yield a clear diagnosis, prompting the need for other alternatives.
- - This case study highlights the successful use of a [99mTc]Tc-Tektrotyd SPECT/CT scan as a non-invasive method for diagnosing orbital tumors, leveraging the radiopharmaceutical's ability to bind to somatostatin receptor subtype 2 found in meningiomas.
Unusual False Positive on Tc-Tektrotyd Scintigraphy Mimicking Bone Metastasis.
Nucl Med Mol Imaging
December 2023
Nuclear Medicine Department, Mohammed VI University Hospital, Cadi Ayyad University, Marrakech, Morocco.
Somatostatin receptor scintigraphy is a key diagnostic tool in the initial staging and therapeutic evaluation of neuroendocrine tumors. Its specificity can be compromised by the presence of false positives. We illustrate here the case of a vertebral hemangioma detected on Tc-Tektrotyd scintigraphy as an incidental finding in a 34-year-old man referred for the staging of a well-differentiated neuroendocrine tumor of the ampulla of Vater (Fig.
View Article and Find Full Text PDFPotential utility of SPECT/CT with 99mTc-Tektrotyd for imaging of post-myocardial infarction inflammation.
J Nucl Cardiol
December 2023
Cardiac Emergency Department, Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences, Tomsk, Russian Federation.
Background: There is a need to develop methods for post-myocardial infarction (MI) inflammation monitoring. Scintigraphy with somatostatin receptor targeted radiotracers has potential in this field. The purpose was to study the association of Tc-Tektrotyd uptake intensity in MI area with heart contractility indices over 6-month follow-up.
View Article and Find Full Text PDFUnexpected Detection of Skeletal Muscle Renal Cell Carcinoma Metastasis With 99m Tc-EDDA/HYNIC-Tyr3-Octreotide (Tektrotyd) Scan.
Clin Nucl Med
December 2022
From the Departments of Nuclear Medicine.
Somatostatin receptor scintigraphy with 99m Tc-Tektrotyd is widely used for the investigation of neuroendocrine tumors. Overexpression of somatostatin receptors has been shown in different tumor types including lymphomas, breast carcinoma, and renal cell carcinoma (RCC). Isolated case reports have shown that RCC metastases can be identified using somatostatin receptor imaging such as Octreoscan scintigraphy and 68 Ga-DOTATATE PET/CT.
View Article and Find Full Text PDFDiagnostic and prognostic value of Tc-Tektrotyd scintigraphy and F-FDG PET/CT in a single-center cohort of neuroendocrine tumors.
Arch Med Sci
March 2021
Center for Nuclear Medicine and PET, University Clinical Center of Serbia, Belgrade, Serbia.
Introduction: The aim was to assess the diagnostic value of Tc-Tektrotyd scintigraphy (TCT) and positron emission tomography/computed tomography using F-18 fluorodeoxyglucose (F-FDG PET/CT) in the detection and follow-up of neuroendocrine tumors (NETs), and their predictive value for disease progression.
Material And Methods: In this retrospective cohort, TCT and F-FDG PET/CT were performed in 90 patients (37 men, 53 women, mean age 52.7 ±15.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!